Becton Dickinson BDX
NYSE BDX
$176.42 -3.38 (-1.88%)
As of: Sep 10, 2026 · 3:59 PM EDT

Becton Dickinson (BDX) Research & Development (2009 - 2026)

Becton Dickinson's (BDX) quarterly Research & Development came in at $258.0 million in Q2 2026, up 12.17% year-over-year from $230.0 million in Q2 2025, and up 3.61% quarter-over-quarter from $249.0 million in Q1 2026.

Analysis

Becton Dickinson (BDX) Research & Development (2009 - 2026) Analysis & Trends

Becton Dickinson (BDX) has reported Research & Development for 18 consecutive years, with $258.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Research & Development rose 12.17% year-over-year to $258.0 million in Q2 2026; TTM through Jun 2026 was $1.4 billion, a 23.94% increase from a year earlier, with the FY2025 full-year figure at $1.3 billion, up 6.3% from the prior year.
  • Research & Development was $258.0 million for Q2 2026 at Becton Dickinson, up from $249.0 million in the prior quarter.
  • Over five years, Research & Development peaked at $559.0 million in Q3 2025 and troughed at $230.0 million in Q2 2025.
  • A 5-year average of $308.1 million and a median of $301.0 million in 2022 frame the typical range for Research & Development.
  • The widest YoY moves for Research & Development: up 85.1% in 2025, down 23.08% in 2025.
  • Over 5 years, Research & Development stood at $313.0 million in 2022, then decreased by 7.35% to $290.0 million in 2023, then increased by 18.28% to $343.0 million in 2024, then dropped by 10.79% to $306.0 million in 2025, then declined by 15.69% to $258.0 million in 2026.
  • The last three Research & Development figures came in at $258.0 million (Q2 2026), $249.0 million (Q1 2026), and $306.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Becton Dickinson 48.41 Bn 47.55 Bn 2.32 Bn 258.00 Mn
2 Medline 27.78 Bn 25.10 Bn 2.22 Bn -
3 West Pharmaceutical Services 24.42 Bn 23.98 Bn 329.20 Mn 19.70 Mn
4 Baxter International 12.49 Bn 10.34 Bn 1.03 Bn 129.00 Mn
5 Stevanato Group S.p.A 5.70 Bn 5.59 Bn 100.91 Mn 7.22 Mn
6 Acme United 235.29 Mn 230.25 Mn 26.69 Mn -
7 Rockwell Medical 31.39 Mn 6.60 Mn 3.24 Mn 577,000.00
8 Retractable Technologies 21.15 Mn -18.72 Mn 190,852.00 1.53 Mn
9 United Health Products 8.85 Mn 8.82 Mn - 3,852.00
10 Cuprina Holdings (Cayman) 7.88 Mn 4.76 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 258.00 Mn
Mar 31, 2026 249.00 Mn
Dec 31, 2025 306.00 Mn
Sep 30, 2025 559.00 Mn
Jun 30, 2025 230.00 Mn
Mar 31, 2025 232.00 Mn
Dec 31, 2024 343.00 Mn
Sep 30, 2024 302.00 Mn
Jun 30, 2024 299.00 Mn
Mar 31, 2024 299.00 Mn
Dec 31, 2023 290.00 Mn
Sep 30, 2023 281.00 Mn
Jun 30, 2023 306.00 Mn
Mar 31, 2023 337.00 Mn
Dec 31, 2022 313.00 Mn
Sep 30, 2022 300.00 Mn
Jun 30, 2022 315.00 Mn
Mar 31, 2022 327.00 Mn
Dec 31, 2021 314.00 Mn
Sep 30, 2021 368.00 Mn